vs
巴诺书店（NE）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
巴诺书店的季度营收约是Royalty Pharma plc的1.2倍（$764.4M vs $622.0M），Royalty Pharma plc净利率更高（34.4% vs 11.3%，领先23.1%），Royalty Pharma plc同比增速更快（4.8% vs -17.6%），过去两年巴诺书店的营收复合增速更高（9.5% vs 4.6%）
巴诺书店是美国知名连锁图书零售企业，拥有全美数量最多的实体零售网点，目前在美国境内共运营超过700家线下门店，为消费者提供各类书籍、文创产品及相关文化消费服务。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
NE vs RPRX — 直观对比
营收规模更大
NE
是对方的1.2倍
$622.0M
营收增速更快
RPRX
高出22.3%
-17.6%
净利率更高
RPRX
高出23.1%
11.3%
两年增速更快
NE
近两年复合增速
4.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $764.4M | $622.0M |
| 净利润 | $86.6M | $214.2M |
| 毛利率 | — | — |
| 营业利润率 | 5.6% | 62.4% |
| 净利率 | 11.3% | 34.4% |
| 营收同比 | -17.6% | 4.8% |
| 净利润同比 | -10.4% | 2.9% |
| 每股收益（稀释后） | $0.54 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NERPRX
| Q4 25 | $764.4M | $622.0M | ||
| Q3 25 | $798.0M | $609.3M | ||
| Q2 25 | $848.7M | $578.7M | ||
| Q1 25 | $874.5M | $568.2M | ||
| Q4 24 | $927.3M | $593.6M | ||
| Q3 24 | $800.5M | $564.7M | ||
| Q2 24 | $692.8M | $537.3M | ||
| Q1 24 | $637.1M | $568.0M |
净利润NERPRX
| Q4 25 | $86.6M | $214.2M | ||
| Q3 25 | $-21.1M | $288.2M | ||
| Q2 25 | $42.9M | $30.2M | ||
| Q1 25 | $108.3M | $238.3M | ||
| Q4 24 | $96.6M | $208.2M | ||
| Q3 24 | $61.2M | $544.0M | ||
| Q2 24 | $195.0M | $102.0M | ||
| Q1 24 | $95.5M | $4.8M |
营业利润率NERPRX
| Q4 25 | 5.6% | 62.4% | ||
| Q3 25 | 6.3% | 70.1% | ||
| Q2 25 | 15.9% | 36.3% | ||
| Q1 25 | 21.4% | 94.0% | ||
| Q4 24 | 18.4% | 60.9% | ||
| Q3 24 | 14.4% | — | ||
| Q2 24 | 30.3% | 50.2% | ||
| Q1 24 | 16.9% | -13.0% |
净利率NERPRX
| Q4 25 | 11.3% | 34.4% | ||
| Q3 25 | -2.6% | 47.3% | ||
| Q2 25 | 5.1% | 5.2% | ||
| Q1 25 | 12.4% | 41.9% | ||
| Q4 24 | 10.4% | 35.1% | ||
| Q3 24 | 7.6% | 96.3% | ||
| Q2 24 | 28.1% | 19.0% | ||
| Q1 24 | 15.0% | 0.8% |
每股收益（稀释后）NERPRX
| Q4 25 | $0.54 | $0.49 | ||
| Q3 25 | $-0.13 | $0.67 | ||
| Q2 25 | $0.27 | $0.07 | ||
| Q1 25 | $0.67 | $0.55 | ||
| Q4 24 | $0.56 | $0.46 | ||
| Q3 24 | $0.40 | $1.21 | ||
| Q2 24 | $1.34 | $0.23 | ||
| Q1 24 | $0.66 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $471.4M | $618.7M |
| 总债务越低越好 | — | $9.0B |
| 股东权益账面价值 | $4.5B | $9.7B |
| 总资产 | $7.5B | $19.6B |
| 负债/权益比越低杠杆越低 | — | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资NERPRX
| Q4 25 | $471.4M | $618.7M | ||
| Q3 25 | $477.9M | $938.9M | ||
| Q2 25 | $338.2M | $631.9M | ||
| Q1 25 | $303.8M | $1.1B | ||
| Q4 24 | $247.3M | $929.0M | ||
| Q3 24 | $391.9M | $950.1M | ||
| Q2 24 | $162.9M | $1.8B | ||
| Q1 24 | $212.5M | $843.0M |
总债务NERPRX
| Q4 25 | — | $9.0B | ||
| Q3 25 | — | $8.9B | ||
| Q2 25 | — | $8.0B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | — | $7.6B | ||
| Q3 24 | — | $7.6B | ||
| Q2 24 | — | $7.6B | ||
| Q1 24 | — | $6.1B |
股东权益NERPRX
| Q4 25 | $4.5B | $9.7B | ||
| Q3 25 | $4.5B | $9.6B | ||
| Q2 25 | $4.6B | $9.5B | ||
| Q1 25 | $4.7B | $9.8B | ||
| Q4 24 | $4.7B | $10.3B | ||
| Q3 24 | $4.7B | $10.3B | ||
| Q2 24 | $4.0B | $9.8B | ||
| Q1 24 | $3.9B | $9.9B |
总资产NERPRX
| Q4 25 | $7.5B | $19.6B | ||
| Q3 25 | $7.6B | $19.3B | ||
| Q2 25 | $7.7B | $18.3B | ||
| Q1 25 | $7.9B | $17.6B | ||
| Q4 24 | $8.0B | $18.2B | ||
| Q3 24 | $8.0B | $18.0B | ||
| Q2 24 | $5.6B | $17.7B | ||
| Q1 24 | $5.4B | $16.1B |
负债/权益比NERPRX
| Q4 25 | — | 0.92× | ||
| Q3 25 | — | 0.93× | ||
| Q2 25 | — | 0.84× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.78× | ||
| Q1 24 | — | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $187.1M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $35.4M | — |
| 自由现金流率自由现金流/营收 | 4.6% | — |
| 资本支出强度资本支出/营收 | 19.9% | — |
| 现金转化率经营现金流/净利润 | 2.16× | 3.86× |
| 过去12个月自由现金流最近4个季度 | $432.2M | — |
8季度趋势，按日历期对齐
经营现金流NERPRX
| Q4 25 | $187.1M | $827.1M | ||
| Q3 25 | $277.1M | $702.6M | ||
| Q2 25 | $216.4M | $364.0M | ||
| Q1 25 | $271.1M | $596.1M | ||
| Q4 24 | $136.2M | $742.5M | ||
| Q3 24 | $283.8M | $703.6M | ||
| Q2 24 | $106.8M | $658.2M | ||
| Q1 24 | $128.7M | $664.6M |
自由现金流NERPRX
| Q4 25 | $35.4M | — | ||
| Q3 25 | $139.5M | — | ||
| Q2 25 | $99.8M | — | ||
| Q1 25 | $157.5M | — | ||
| Q4 24 | $-4.4M | — | ||
| Q3 24 | $156.8M | — | ||
| Q2 24 | $-34.3M | — | ||
| Q1 24 | $-37.9M | — |
自由现金流率NERPRX
| Q4 25 | 4.6% | — | ||
| Q3 25 | 17.5% | — | ||
| Q2 25 | 11.8% | — | ||
| Q1 25 | 18.0% | — | ||
| Q4 24 | -0.5% | — | ||
| Q3 24 | 19.6% | — | ||
| Q2 24 | -4.9% | — | ||
| Q1 24 | -6.0% | — |
资本支出强度NERPRX
| Q4 25 | 19.9% | — | ||
| Q3 25 | 17.3% | — | ||
| Q2 25 | 13.7% | — | ||
| Q1 25 | 13.0% | — | ||
| Q4 24 | 15.2% | — | ||
| Q3 24 | 15.9% | — | ||
| Q2 24 | 20.4% | — | ||
| Q1 24 | 26.2% | — |
现金转化率NERPRX
| Q4 25 | 2.16× | 3.86× | ||
| Q3 25 | — | 2.44× | ||
| Q2 25 | 5.05× | 12.06× | ||
| Q1 25 | 2.50× | 2.50× | ||
| Q4 24 | 1.41× | 3.57× | ||
| Q3 24 | 4.64× | 1.29× | ||
| Q2 24 | 0.55× | 6.45× | ||
| Q1 24 | 1.35× | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NE
| Floaters | $559.8M | 73% |
| Jackups | $145.5M | 19% |
| Service Other | $59.1M | 8% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
